Piglet models of acute or chronic Clostridium difficile illness.
about
Clostridium difficile in the ICU: the struggle continuesClostridium difficile infection: molecular pathogenesis and novel therapeuticsHuman microbiota-associated swine: current progress and future opportunitiesThe roles of toxin A and toxin B in Clostridium difficile infection: insights from the gnotobiotic piglet model.Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregation-promoting functionA novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.Temporal differential proteomes of Clostridium difficile in the pig ileal-ligated loop modelBeneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.A pig model of the human gastrointestinal tract.Muricholic acids inhibit Clostridium difficile spore germination and growthPrevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population.Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism.Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet modelIdentification of toxemia in patients with Clostridium difficile infection.Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infectionSystemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal modelsA Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift.Models for the study of Clostridium difficile infection.A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain.Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease.The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challengeMBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic pigletsA Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection.The enterotoxicity of Clostridium difficile toxins.Clostridium difficile in foods and animals: history and measures to reduce exposure.Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile.Carbohydrate-based Clostridium difficile vaccines.Large animal models for vaccine development and testing.Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.Mouse relapse model of Clostridium difficile infection.Miniature Swine for Preclinical Modeling of Complexities of Human Disease for Translational Scientific Discovery and Accelerated Development of Therapies and Medical Devices.Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.Both, toxin A and toxin B, are important in Clostridium difficile infection.A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominisFormula-feeding predisposes neonatal piglets to Clostridium difficile gut infection.Diarrhoea in neonatal piglets: a case control study on microbiological findings
P2860
Q26823000-584C7531-69A6-455C-BD4A-6BC14A4D557CQ26864237-ABE6EBDB-448F-4E53-928D-A5FC7056A46EQ28084906-E16E3EDA-1230-4CB0-A44D-94F1983400ECQ33728318-4DF54B7A-2931-4FE0-B2D4-36F140B8D208Q33728333-900AA4DA-EFBC-4F33-9277-1B8BD526C1B1Q33886149-C97B1E12-ACF6-425D-A03D-6D92885D2B72Q34315655-573C8FF2-543B-4919-9C97-EEA2EE4BA677Q34429581-63D94A1D-FAB2-4DD0-A0C3-B57FFFAD5885Q34597557-A274C2DD-EC93-4B57-B98A-3C01F36AD270Q34645922-61F2A28A-8DB6-46ED-B078-5DD902AF8014Q34989047-7E4998EB-B68A-4D47-B04B-6F8206307201Q35191338-B7F453FC-A68E-4E70-BB08-38D411871D57Q35224435-802B2B7D-796D-4BB2-93F1-235628A2FED5Q35368495-08BBDB81-83C3-4F24-BB19-6EDC80B152E0Q35465119-C0351172-97C3-4973-B1E1-B0340CF95505Q35661928-8E12433B-D34E-40F5-B87A-431FF781595FQ35669017-2B53B6B0-E5D6-473A-92F5-5CAD65831842Q35904265-F5C73CA8-21C6-4217-8E4B-201B48B0F47DQ36019356-A8946CE3-AFC0-4200-AFCB-FF0F847A272EQ36211064-F0D85D41-0C78-4590-A196-DC9DE7164CB7Q36328439-9547736D-03BC-43F9-AEBC-D620ACF47A1AQ36410918-E3F4D095-23EB-4B24-AEC5-7F7801FBBC16Q36495548-FAA3A7D8-0183-42CC-8518-BA8B36C69212Q36889259-8CF5B705-9328-43B1-8687-F0CB0FB88699Q37036559-689AEB8D-C287-4159-A003-826CBA7E3CB9Q37239550-4C4DC090-56FC-4002-AD01-609561C11D13Q37954308-136A1461-36CD-498A-83FB-F7CA989F9D86Q38074514-347942C1-4ED6-4887-A521-2AE4683BBFBAQ38084060-F2FD76D4-1A34-4258-AF87-4A9035B0255BQ38096491-D4A5ADB8-907D-4398-847C-464F63095239Q38492768-7952101E-2376-4F16-BA15-5A7BAC9CFAD8Q38610159-A2C2F787-EE95-4F30-BAA5-4865851D58C2Q38686746-405CC49A-67DB-4039-84B2-B1614DD6E148Q38721240-73AA4796-BDC0-46EE-9574-DD4DEAE10B86Q40233875-54E0693E-6556-48AB-AF9B-F371325F6F98Q40478915-64A2AC7C-4306-47FA-905B-178676B6003AQ41434690-AAE2239E-8481-4730-B0E3-7EC510453DF9Q41991627-D722AACE-18D3-439D-9E06-A90CF3DA51D1Q47620755-AAA0A299-44E5-452B-8834-8EC6369CE4E2Q56515319-DFB4A5A1-0997-4220-BD6D-3825F57C0772
P2860
Piglet models of acute or chronic Clostridium difficile illness.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Piglet models of acute or chronic Clostridium difficile illness.
@ast
Piglet models of acute or chronic Clostridium difficile illness.
@en
Piglet models of acute or chronic Clostridium difficile illness.
@nl
type
label
Piglet models of acute or chronic Clostridium difficile illness.
@ast
Piglet models of acute or chronic Clostridium difficile illness.
@en
Piglet models of acute or chronic Clostridium difficile illness.
@nl
prefLabel
Piglet models of acute or chronic Clostridium difficile illness.
@ast
Piglet models of acute or chronic Clostridium difficile illness.
@en
Piglet models of acute or chronic Clostridium difficile illness.
@nl
P2860
P356
P1476
Piglet models of acute or chronic Clostridium difficile illness.
@en
P2093
Hanping Feng
Jennifer Steele
P2860
P304
P356
10.1086/649799
P407
P577
2010-02-01T00:00:00Z